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The serum myeloma globulins produced in 20 transplantable mouse plasma 
cell  tumors were classified in a  previous study (1)  into two major groups on 
the basis of distinctive antigenic properties. One of these groups was clearly 
related antigenically to the normal gamma globulins. The second group of mye- 
loma globulins, however, was antigenically related to a normal component with 
the electrophoretic mobility of a beta globulin. Although it seemed likely that 
this second group  of myeloma proteins and the  corresponding normal com- 
ponent were analogous to the 0,x-globulins of human serum, the notably faster 
electrophoretic mobility of the normal mouse component and the inability to 
demonstrate common antigens between the  human and mouse globulins in- 
dicated the need for further information on the mouse myeloma globulins. 
In  the  present  study  the  physicochemical characterization  of  20  mouse 
myeloma proteins was undertaken. It was known from earlier studies that the 
myeloma proteins  associated  with  2  transplantable  mouse  tumors  differed. 
The myeloma proteins formed in the 5563  plasma cell tumor were shown to be 
gamma globulins sedimenting as a single 6.5 S component in the ultracentrifuge 
(2, 3). Differing in many properties, however, was the beta  myeloma protein 
associated with the 5647  tumor, which was shown by ultracentrifugation to 
contain 9, 11, and 13 S components (4). This evidence of heterogeneity and the 
finding of Askonas (3)  that the 5563  myeloma protein  contained 5  discrete 
components detectable by starch gel electrophoresis stimulated an investiga- 
tion of the types and frequency of heterogeneity among the mouse myeloma 
proteins.  Individually, the  mouse myeloma proteins  were  notable  for  their 
heterogeneity and individual differences. Taken together the myeloma proteins 
were notable for the wide range of properties observed as well as for the physico- 
chemical differences between gamma and beta  type globulins. The physico- 
chemical features of the mouse myeloma proteins allowed a direct comparison 
with the analogous proteins in man. 
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Materials and Methods 
The myeloma sera were obtained as described previously (1).  Total serum 
protein levels were measured by the biuret technique and the concentration of 
serum electrophoretic components determined by quantitative paper electro- 
phoresis (5). The hexose and cholesterol measurements were made by standard 
procedures (5). The distribution of lipid and carbohydrate (hexose) among the 
serum electrophoretic groups was determined by oil red O (6) and periodic acid- 
Schiff (7)  staining techniques. Normal values were obtained by the analysis 
of  three  pools  of  sera  and  two  individual sera.  No  difference between  the 
normal sera of CsH and BALB/c strains of mice was detected by paper elec- 
trophoretic  procedures. 
Moving  boundary  electrophoresis  was  carried  out  in  an  Aminco-Stern 
apparatus at I°C in pH 8.6, 0.1X veronal buffer by Dr. J. J. Finlayson of the 
Division  of  Biological Standards,  National  Institutes  of  Health.  Mobilities 
are expressed as the mean value obtained from both the ascending and descend- 
ing  patterns. 
Starch gel electrophoresis was carried out by the technique of Smithies (8, 3), 
employing 0.03 M tris borate pH 9.2 or 0.05 M pH 8.9 glycine buffer. 
Ultracentrifugation was carried out in a  Spinco model E  No.  40 rotor at 
59,780  RPM at approximately 25°C.  Sera were diluted with 0.15  M NaC1  to 
approximately 1.2 gm per cent concentration and isolated proteins were dialyzed 
against a  saline-phosphate pH  7.6  buffer prior  to analysis (9).  Photos were 
taken 10 minutes after the rotor reached full speed and at 16 minute intervals 
thereafter. Most analyses were carried out with the counterbalance replaced by 
a  second cell having a  1  ° angle face. The mean data from analyses of three 
different samples of the 5563, 5647, SPC-1, DPC-1, MPC-1, 2, 3, and 4 myeloma 
sera and single analyses of the remaining myeloma sera are presented. 
Chromatography was  conducted  on  anion  exchange  columns  of  diethyl- 
aminoethyl (DEAE) cellulose (10). The samples to be analyzed were dialyzed 
to equilibrium against a  potassium phosphate buffer of pH 8 and phosphate 
concentration of 0.02 M and then applied to columns containing 2 gm of the 
absorbent,  equilibrated  against  the  same  buffer.  Elution  of  proteins  was 
achieved by a gradient increase in ionic strength while maintaining pH 8 and 
employing a  total volume of  150  ml  (9).  The protein  concentration in  the 
effluent was determined by measurement of the optical density at 280  m/z in a 
Beckman DU spectrophotometer. 
RESL~,TS 
Each of the myeloma proteins  examined, 4 from tumors in C3H mice and 16 
from BALB/c  mice, had distinctive  individual features. Quantitative and 
qualitative  data for each of the myeloma proteins  are given in Table I. The 2 
myeloma proteins classified  as gamma  globulins  on the basis of distinctive 5~  m 
g  :g 
~~l  .......... 
•  © 
~  ~.~  ~  ~  ~  ~  ~  ~  ~  ~  ~  ~  ~  ~  ~  ~  ++~  ~  ~  ~.  ~ 
t¢3  ,~ 
~--*  ++ 
++ 
22 
I÷ 
~  t¢3 
=  ;.; 
o~  ~ 
Z  ~ 
'.~'~ 
~'~ 
~.~ ~ 
+  + 
I 
I  I 
o 
.o 
o~ 
II  °~ 
e~ 
o 
~o 
401 402  MOUSE  MYELOMA  PROTEINS 
antigenic properties have been separated from the  18 proteins wit h beta (~2~) 
antigenic properties. 
Zone  Eleclrophoresis.--Distinctive  components  representing  myeloma  pro- 
teins were readily detected on paper electrophoresis of sera from mice bearing 
transplantable  plasma  cell  tumors.  A  wide  range  of  myeloma  t)rolein  elec- 
trophoretie mobilities was associated with  the plasma  cell  tumors of the C:~H 
and  BALB/c strains of mice. Tumors 5563,  5647,  SP('-I, and  1)I)('-1  in  C:~H 
mice produced myeloma proteins of gamma, beta, or alpha-3 globulin mobility 
(Fig. 1). Similarly, tumors in BALB/c mice produced myeloma proteins ranging 
in electrophoretic mobility from gamma to alpha-3 globulins (Table 1,  Fig.  1). 
FIG. 1. Paper electrophoretic  analyses of normal sera are compared  with sera obtained from 
mice bearing transplantable plasma cell tumors. 
Quantitative  analyses  (Table  I)  revealed  that  the  myeloma  proteins  were 
present in concentrations of as much as  7 gm per cent in  representative sera. 
Moving  boundary  electrophoresis of  normal  mouse  serum  revealed  peaks 
corresponding to the albumin,  alpha-l, -2,  and  -3,  beta,  and  gamma  globulin 
regions  of paper  electrophoresis.  Analysis  of  5647  sera  revealed  a  relatively 
broad myeloma protein peak with mobility of 3.3  X  10  -'~' ctn"/' volt sec.  (beta 
globulin). MPC-I serum contained a more discrete myeloma protein peak with 
a  mobility of 4.5  )<  10  -5 cm2/volt sec.  (alpha-3 globulin). 
The  electrophoretic  mobility  of  the  MPC-15  myeloma  protein  was  not 
determined  for this protein precipitated in 0.01  M pH  7.4  sodium  phosphate 
buffer and  was  insoluble  in  the  buffers  used  for paper,  starch  gel,  and  im- 
munoelectrophoresis (see Fig. 4 of reference 1). 
Ullracentrifugation.--Ultracentrifugal  analyses of normal  C:~H and BALB/'c 
mouse  serum  revealed  components,  with  sedimentation  coefficients (s20,~,) of 
4,  6.5,  and  17  S  (Fig.  2) which appear to be qualitatively and quantitatively JOHN  L.  FAHEY  403 
FIG. 2. Ultracentrifugal analysis of sera obtained from mice bearing transplantable plasma 
cell tumors. Photos were taken 39, 38, and 38 minutes after reaching full speed  (59, 780 ~PM) 
for the normal C3H, 5563, and 5647 sera respectively and at 42 minutes for the remaining 
sera.  Ultracentrifugation was performed at  1.2 to  1.4 gm per cent concentration for all sera. 
An aliquot of the DPC-1 sample was analyzed after dialysis against 0.1 M mercaptoethanol. 
comparable respectively to  the 4,  6.6,  and  18 S  components of normal human 
serum (Table I). Sera containing gamma myeloma proteins, 5563 and MPC-11, 
showed  marked  increases of the  6.5  S  component  (Fig.  5)  with reduced  levels 
of the  4  and  17  S  components indicating that  the myeloma proteins are corn- .4134  MOUSE  MYELOMA  PROTEINS 
posed only of 6.5  S molecules.  This was confirmed by ultracentrifugal  analysis 
of  the  purified  myeloma  globulins.  All  of  the  beta  type  myeloma  proteins, 
however,  were  shown  to  be  heterogeneous,  and  typically  contained  multiple 
ultracentrifugal  components  with  sedimentation  coefficiems of 6.5,  9,  and  11 
Ft(;. 3. Starch gel electrophoresis of mouse myeloma sera using 0.03 M  1)H 9.2 tris phoslHmte 
Imffer and a discontinuous buffer system, (8, 3). 
and 13 S (Fig. 2). The relative amount of these four ultracentrifugal components 
varied.  In some sera,  such as 5647,  the myeloma protein appeared  to be made 
up almost entirely of 9, ll, and 13 S components, whereas in MPC-1  serum the 
myeloma protein was largely 6.5 S. Usually the  11 S component  was present  in 
the lowest amount,  and  more 9 and  13  S components were found. 
Multiple  component myeloma sera  from mice bearing  tumors 5647,  SP('-I, 
DPC-1, MPC-1, 2, 3, and 4 were treated with 0.1  M mercaptoethanol according 405 
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to the  technique  of Deutsch and  Morton  (11).  In all  sera the 9,  11,  and  13  S 
components were reduced and a corresponding increase in the 6.5 S component 
was found on re-analysis in the ultracentrifuge  (Fig. 2). A similar finding with 
mercaptoethanol  treatment  of  gamma  macroglobulins,  which  indicated  thai 
the macroglobulins resulted from polymerization of 6.6 S molecules (11), make 
it likely that the 9, 11, and 13 S components of beta type mouse myeloma globu- 
lins result from polymerization or aggregation of 6.5 S molecules. 
TABLE II 
Tumor type 
Normal ........................ 
5563  .......................... 
5647  ........................... 
SPC-1  .......................... 
DPC-1 ........................ 
MPC-1 ......................... 
MPC-2 ......................... 
MPC-3 ......................... 
MPC-4 ......................... 
IIexose content  of myeloma protein 
(per cent of protein) 
Paper 
electrophoresis* 
0.94 
2.7 
3.6 
3.6 
3.5 
3.1 
2.7 
3.7 
Purified protein 
1.28 
O. 98 
1.8 
Cholesterol  content 
myeloma sera 
mg per cent 
88~ 
29 
82 
65 
84 
31 
38 
63 
68 
* Hexose content  calculated from quantitative values obtained  by whole serum analyses 
for protein  and protein-bound  hexose and from the protein  and  carbohydrate  distribution 
determined by paper electrophoresis. 
~t Mean  normal serum cholesterol value  =  88 mg per cent  (q-  2 S.D.  =  65 to 115 nag 
per cent). 
Starch  Gel  Electrophoresis.--Each  of the  myeloma globulins  was distinctive 
in its behavior on starch gel electrophoresis, confirming the individuality of the 
myeloma globulins.  Furthermore, all of the 20 myeloma globulins were hetero- 
geneous. Starch gel electrophoretic results for representative  sera are shown in 
Fig. 3, where two or more bands are seen for each of the beta type myeloma 
proteins, Where ultracentrifugation  revealed the myeloma protein to be largely 
a 6.5 S globulin (see MPC-1), the major component has migrated relatively far 
on starch  gel electrophoresis,  consistent  with  the  zone electrophoretic  results. 
Beta myeloma proteins which are made up largely of 9, 11, and 13 S components 
(see 5647) reveal components which have migrated poorly in the gel and bands 
are  seen  in  the gamma globulin region,  attributable  to the  slow migration  in 
starch gel of the larger 9, 11, or 13 S components. Thus, starch gel electropho- 
resis  also reveals  the polymer type heterogeneity  seen  on ultracentrifugation. 408  MOUSE  MYELOMA  PROTI~;INS 
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By employing  modified starch gel electrophoretic  procedures  the MPC-11 
gamma myeloma protein was shown to be composed of at least 5 individual 
components  (Fig. 4). This same type of heterogeneity was shown previously in 
the 5563 myeloma proteins by Askonas  (3). The separate components  of the 
myeloma  globulin are not attributable to polymer formation since ultracentrifu- 
gation reveals only 6.5 S components. The individual components of the 5563 
globulin (3) and the MPC-11 protein can be separated by anion-exchange cellu- 
lose chromatography, further indicating that charge and not size differences ac- 
count for the findings on starch gel electrophoresis.  The finding of multiple 
components differing  in  charge  within a  single myeloma globulin  has  been 
designated electrophoretic heterogeneity. 
Chromatography.--Fractionation  of  serum  on  columns  of  anion-exchange 
(DEAE) cellulose was useful both in the characterization and purification  of 
the  myeloma proteins.  The  chromatographic  behavior of the  5563 gamma 
myeloma protein and the 5647 beta myeloma proteins under standard condi- 
tions,  employing pH 8 buffers and an eluting phosphate gradient from 0.02 
M to 0.30 M, are illustrated in Fig. 5. The MPC-11  gamma myeloma protein 
behav.ed similarly to that illustrated for 5563 protein. The chromatographic 
elution site correlated  in a general way with the electrophoretic  mobility, the 
slower migrating myeloma proteins being eluted earlier. 
Carbohydrate and Lipid Content.--The  carbohydrate, hexose, content of the 
myeloma proteins differed (Table II). The gamma type 5563 myeloma protein 
had a hexose content of about 1 per cent, close to that of normal gamma globu- 
lin,  which is about 1.2 per cent. The 7 beta type myeloma globulins tested, 
however, had higher hexose levels with values  ranging from 2 to 4 per cent. 
The variation in hexose content appeared to increase in a  general way with 
the increase in myeloma protein electrophoretic  mobility (Fig. 6). 
None of the myeloma proteins was found to have lipid. The oil red O staining 
of paper electrophoretic  strips failed to reveal any neutral fat in the myeloma 
protein region and, on the basis of the low cholesterol value in these sera (Table 
II) none of the myeloma proteins is believed to contain cholesterol. 
DISCUSSION 
Physicochemical  observations  support the division of mouse myeloma pro- 
teins into two groups, the "y-type and the/~-type (Table III). The h'-myeloma 
proteins,  in  addition to  sharing  many antigenic determinants with normal 
mouse gamma globulin  (1)  also showed only 6.5  S components  in the ultra- 
centrifuge, migrated electrophoretically  as gamma globulins, and had a hexose 
content of about 1 per cent. The/~-type myeloma proteins,  on the other hand, 
migrated as 8- or even a-globulins on electrophoresis,  contained multiple (9, 
11,  and  13  S)  ultracentrifugal components,  and had higher hexose contents 
(2 to 4 per cent) as well as distinctive antigenic properties. 410  MOUSE  MYELOMA  PROTEINS 
Each of the 20 mouse myeloma proteins was heterogeneous. The polymer- 
type heterogeneity, previously noted on ultracentrifugation of the beta type 
5647 myeloma protein (4),  was found in a variable degree with all of 18 beta 
type myeloma proteins. This type of heterogeneity was discernible on starch 
gel  electrophoresis where the migration of the larger components is impeded 
in the starch gel. That this type of heterogeneity is due to polymer formation 
was  indicated by the regularity of progression in  sedimentation coefficients 
(9, 11, and 13 S) of the myeloma protein components, consistent with the exist- 
ence of polymers containing 2, 3, and 4 units of 6.5 S globulin, as well  as  by 
the observation that most of the larger components in each myeloma protein 
are reduced to a sedimentation coefficient of 6.5 S by treatment with mercapto- 
ethanol. 
TABLE  III 
Physicochemical Features of Two Types of Mouse Myeloma Proteins 
1.  Electrophoretic mobility ...... 
2.  Ultracentrifugal analysis ...... 
3.  Starch gel electrophoresis ..... 
4.  Hexose content ............... 
5.  DEAE-celhilose chromatographic 
adsorption ................. 
Gamms type 
Gamma 
6.5S 
Electrophoretic 
heterogeneity 
About 1 per cent 
Requires relatively low 
ionic strength 
Beta (82A)  type 
Beta and alpha 
Typically  9 S,  11 S,  and/ 
or  13 S  components 
present 
Polymer type 
heterogeneity 
2 to 4 per cent 
Adsorbs at higher ionic 
strength 
Starch gel electrophoresis also revealed electrophoretic heterogeneity among 
the gamma myeloma proteins, shown already by Askonas for the 5563 globulins 
(3).  These myeloma globulins contain multiple components which have  the 
same or similar ultracentrifugal behavior (about 6.5 S) but differ significantly 
in elution from DEAE-cellulose columns as well as in migration on starch gel 
electrophoresis. 
The  heterogeneity of  the  serum  myeloma protein  reflects the  significant 
capacity of plasma cell tumors to form multiple products. The observed heter- 
ogeneity could result: (a) if each tumor was made up of a single cell line with 
each cell  producing  the several  components of the myeloma protein,  or  (b) 
if each  tumor  was  composed of  several  cell lines,  each  producing  a  single 
component, or  (c)  if homogeneous proteins were produced by the malignant 
cells  but  subsequent  metabolic effects caused  alteration of some.  This  last 
possibility appears to be ruled out by Askonas (3) who identified the multiple 
components of the 5563 myeloma protein in extracts from tumor ribosomes. If JOHN  L.  FAHEY  411 
the tumors were composed of several cell lines or if polymorphism among the 
tumor cells was responsible for the heterogeneity of myeloma protein it might 
be expected that some significant  change in the distribution of cells and mye- 
loma  globulin  components  would  occur  with  serial  tumor  transplantation. 
However, starch gel electrophoresis of 3563 sera obtained over a 4 year period 
and 35 transplant generations revealed no marked change in the electrophoretic 
heterogeneity for this  protein.  Similarly,  heterogeneity of the polymer type 
has been present for over 4 years of observation with the 5647 myeloma protein. 
It has not yet been possible to grow tumors from single cell transplants  and 
thus determine the number of proteins formed by a single cell. However, the 
evidence currently available indicates that several myeloma protein components 
are formed in each cell. 
Biosynthetic  studies  (3,  12,  13)  revealed  that  the  myeloma proteins  are 
formed by the tumor but have not proven whether individual malignant cells 
synthesize all or only one of the components comprising  a myeloma protein. 
Nevertheless, it is evident that malignant plasma cells can form only a  limited 
number  of  different  myeloma globulin  molecules.  Although  the  number  of 
physicochemically distinct proteins that can be formed by a single normal plasma 
cell is unknown, if the malignant plasma cells of the tumor are derived  from a 
single  normal  cell,  then  individual  normal  plasma  cells  also may have the 
capacity to synthesize only a limited number of different molecules. 
Comparison of individual properties of the mouse myeloma proteins revealed 
several  general  correlations.  The  physicochemical differences  between mole- 
cules  having  the "},-type or  fl-type antigenic  determinants  have  been noted 
above. It would, of course,  be of great interest to relate individual  antigenic 
determinants  to  specific  physicochemical  features.  Electrophoretic  hetero- 
geneity  was  noted  only  in  the  3"-myeloma  globulins  and  polymer  hetero- 
geneity only with the fl-myeloma globulins  The extent of polymerization did 
not appear to relate to the electrophoretic mobility or the hexose  content of 
the myeloma globulin.  Hexose content, however, correlated roughly with the 
electrophoretic  mobility,  high  hexose  values  being  found  with  more  rapid 
migration. 
The myeloma proteins of the mouse are closely analogous to myeloma pro- 
teins in man. The physicochemical properties of 3"- and/3 (~2A)-myeloma pro- 
teins in man  (14,  15) closely parallel those noted for the mouse in Table III. 
Human  3"-myeloma proteins  similarly  have a  close antigenic  relationship  to 
normal 3,-globulins, show a single 6.5 S ultracentrifugal component, and most 
reveal  electrochemical  heterogeneity on  starch  gel  electrophoresis.  The fl~A- 
myeloma proteins  in  man,  however,  typically reveal  polymer type hetero- 
geneity on starch gel electrophoresis and in the ultracentrifuge, have a higher 
hexose content and absorb on DEAE cellulose at relatively higher ionic strength. 
These  physicochemical  features  of  myeloma  proteins  reflect  the  metabolic 412  MOUSE  MYELOMA PROTEINS 
processes of plasma cells of both mouse and man, and are not species  specific. 
It  is,  of course,  the physicochemical features of the  myeloma proteins  that 
indicate most strongly the resemblance between the products of plasma cells 
in mouse and man. 
SUMMARY 
Physicochemical characterization of mouse myeloma proteins revealed the 
individuality Of each myeloma protein. When the myeloma proteins are con- 
sidered  collectively a  wide range  of individual properties  were  represented, 
including electrophoretic mobilities varying from the gamma to alpha region, 
hexose contents from 1 to 4 per cent, and ultracentrifugal components from 
6.5 to 13 S. The 20 myeloma proteins could be divided into groups, the gamma 
type and the beta type myeloma globulins, on the basis of physicochemical, 
as well as  immunoelectrophoretic, studies.  Two gamma type myeloma pro- 
teins (5563,  MPC-11)  resembled normal gamma globulins, sedimenting as a 
single 6.5  S peak in the  ultracentrifuge, and  having a  relatively low hexose 
content (1 per cent). 
Eighteen beta type mouse myeloma proteins differed from gamma myeloma 
proteins and, typically, were found on ultracentrifugal analysis to have multiple 
components with sedimentation coefficients of 6.5,  9,  11, and  13  S, having a 
higher hexose content (2 to 4 per cent) as well as distinctive chromatographic 
and starch gel electrophoretic properties. 
All of the mouse myeloma proteins were heterogeneous and heterogeneity 
of two types was observed. Polymer formation was responsible for the 9,  11, 
and/or 13 S components seen on ultracentrifugation of the beta type myeloma 
proteins.  Starch  gel  electrophoresis  revealed  this  type  of  heterogeneity as 
relatively widely separated myeloma protein components, presumably owing 
to the retardation effect of starch gel on the electrophoretic migration of the 
larger polymers. Starch gel electrophoresis revealed a  different type of heter- 
ogeneity for the two gamma type myeloma proteins, each of these being shown 
to contain 5 or more components differing only in electrophoretic properties. 
The physicochemical characteristics of the "y-type and/~-type myeloma pro- 
teins in the mouse indicated the close  similarity of these proteins to the 7- 
and /~-~A-myeloma proteins in man. 
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